MTI - Bonds that build brands

Press Releases

MTI Named as Two-Time Finalist in Industry-Wide
Marketing Competition

LANGHORNE, PA (September, 2005) - MTI is pleased to announce that, in its first-ever entry into a pharmaceutical industry-wide marketing competition, both of its submissions for its proprietary flagship product, eXtendRx®, were selected as finalists. For eXtendRx, a unique direct-to-physician communications initiative, this marks an unquestionable validation of the value the program brings to pharmaceutical marketers as an alternative to sales reps or territories. MTI is the leading provider of data-driven, technology-based, direct-to-physician marketing programs that manage brand sales while delivering a higher ROI than traditional approaches.

According to Bill Clapper, president and CEO of MTI, eXtendRx offers capabilities unlike any other marketing asset. eXtendRx is an innovative, turnkey, highly synchronized program designed to drive brand demand in a competitive marketplace, just as the best sales reps do. Through its sophisticated, technology-based components, eXtendRx produces sales and a return on investment that typically exceeds what might be expected with other marketing support initiatives.

The awards competition, sponsored by the publishers of Medical Marketing & Media magazine, featured twelve different categories that attracted more than 480 entries. MTI's two category submissions included the Best Use of Direct Marketing to Healthcare Professionals and the Best Total Integration Program for Companies Under $5 Billion in Sales. Out of all the submissions, only five finalists were selected for each of these two categories.

"Our eXtendRx submissions were pitted up against some of the most comprehensive initiatives in the industry," Clapper added. "These were produced by many of the top firms in the business. The fact that the judges selected our entries in the face of this tight competition clearly demonstrates their recognition of what eXtendRx can really do for pharmaceutical marketers."

MTI offers proprietary, demand-generating products for pharmaceutical marketers using sophisticated, data-driven technologies. These programs, such as its flagship offering, the eXtendRx Sales Optimization Program, deliver customized scientific and promotional information to physicians on a 1:1 basis through highly synchronized, multi-channel, non-rep communications. Return-on-investment through these programs consistently exceeds other methodologies.